These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 15726496)

  • 1. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
    Kachergus J; Mata IF; Hulihan M; Taylor JP; Lincoln S; Aasly J; Gibson JM; Ross OA; Lynch T; Wiley J; Payami H; Nutt J; Maraganore DM; Czyzewski K; Styczynska M; Wszolek ZK; Farrer MJ; Toft M
    Am J Hum Genet; 2005 Apr; 76(4):672-80. PubMed ID: 15726496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 mutations are a common cause of Parkinson's disease in Spain.
    Mata IF; Ross OA; Kachergus J; Huerta C; Ribacoba R; Moris G; Blazquez M; Guisasola LM; Salvador C; Martinez C; Farrer M; Alvarez V
    Eur J Neurol; 2006 Apr; 13(4):391-4. PubMed ID: 16643318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.
    Ishihara L; Gibson RA; Warren L; Amouri R; Lyons K; Wielinski C; Hunter C; Swartz JE; Elango R; Akkari PA; Leppert D; Surh L; Reeves KH; Thomas S; Ragone L; Hattori N; Pahwa R; Jankovic J; Nance M; Freeman A; Gouider-Khouja N; Kefi M; Zouari M; Ben Sassi S; Ben Yahmed S; El Euch-Fayeche G; Middleton L; Burn DJ; Watts RL; Hentati F
    Mov Disord; 2007 Jan; 22(1):55-61. PubMed ID: 17115391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.
    Latourelle JC; Sun M; Lew MF; Suchowersky O; Klein C; Golbe LI; Mark MH; Growdon JH; Wooten GF; Watts RL; Guttman M; Racette BA; Perlmutter JS; Ahmed A; Shill HA; Singer C; Goldwurm S; Pezzoli G; Zini M; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Huskey KW; Laramie JM; DeStefano AL; Baker KB; Itin I; Litvan I; Nicholson G; Corbett A; Nance M; Drasby E; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Al-hinti J; Moller AT; Ostergaard K; Sherman SJ; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    BMC Med; 2008 Nov; 6():32. PubMed ID: 18986508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genealogical studies in LRRK2-associated Parkinson's disease in central Norway.
    Johansen KK; Hasselberg K; White LR; Farrer MJ; Aasly JO
    Parkinsonism Relat Disord; 2010 Sep; 16(8):527-30. PubMed ID: 20621541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.
    Bardien S; Marsberg A; Keyser R; Lombard D; Lesage S; Brice A; Carr J
    J Neural Transm (Vienna); 2010 Jul; 117(7):847-53. PubMed ID: 20544233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
    Goldwurm S; Di Fonzo A; Simons EJ; Rohé CF; Zini M; Canesi M; Tesei S; Zecchinelli A; Antonini A; Mariani C; Meucci N; Sacilotto G; Sironi F; Salani G; Ferreira J; Chien HF; Fabrizio E; Vanacore N; Dalla Libera A; Stocchi F; Diroma C; Lamberti P; Sampaio C; Meco G; Barbosa E; Bertoli-Avella AM; Breedveld GJ; Oostra BA; Pezzoli G; Bonifati V
    J Med Genet; 2005 Nov; 42(11):e65. PubMed ID: 16272257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
    Di Fonzo A; Tassorelli C; De Mari M; Chien HF; Ferreira J; Rohé CF; Riboldazzi G; Antonini A; Albani G; Mauro A; Marconi R; Abbruzzese G; Lopiano L; Fincati E; Guidi M; Marini P; Stocchi F; Onofrj M; Toni V; Tinazzi M; Fabbrini G; Lamberti P; Vanacore N; Meco G; Leitner P; Uitti RJ; Wszolek ZK; Gasser T; Simons EJ; Breedveld GJ; Goldwurm S; Pezzoli G; Sampaio C; Barbosa E; Martignoni E; Oostra BA; Bonifati V;
    Eur J Hum Genet; 2006 Mar; 14(3):322-31. PubMed ID: 16333314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.
    Lesage S; Condroyer C; Lannuzel A; Lohmann E; Troiano A; Tison F; Damier P; Thobois S; Ouvrard-Hernandez AM; Rivaud-Péchoux S; Brefel-Courbon C; Destée A; Tranchant C; Romana M; Leclere L; Dürr A; Brice A;
    J Med Genet; 2009 Jul; 46(7):458-64. PubMed ID: 19357115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrrk2 pathogenic substitutions in Parkinson's disease.
    Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ
    Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of LRRK2 parkinsonism.
    Haugarvoll K; Wszolek ZK
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S205-8. PubMed ID: 20082991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.
    Squillaro T; Cambi F; Ciacci G; Rossi S; Ulivelli M; Malandrini A; Mencarelli MA; Mari F; Renieri A; Ariani F
    J Hum Genet; 2007; 52(3):201-204. PubMed ID: 17235449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.